






Vol.1 , No. 1, Publication Date: Jul. 7, 2014, Page: 6-11
[1] | Nwachukwu, N., Department of Pharmaceutics & Pharmaceutical Technology, University of Port Harcourt, Choba, Rivers State, Nigeria. |
[2] | Emeje, M. O., Department of Pharmaceutical Technology, National Institute for Pharmaceutical Research & Development, Idu, Abuja, Nigeria. |
[3] | Ofoefule, S. I., Department of Pharmaceutical Technology and Industrial Pharmacy, University of Nigeria, Nsukka, Enugu State, Nigeria. |
An in vitro study on the application of Carbopol 971 (CP 971) as a matrix in the formulation of oral sustained release (SR) tablets of theophylline hydrate was carried out. Carbopol 971 was employed as matrix in the concentration range of 10 to 40 % w/w. The matrix tablets were prepared by the wet granulation method with 95% v/v ethanol as the dispersing fluid. Dissolution rate studies on the tablets were carried out over an 8 h period in three media of 0.1 N Hydrochloric acid (HCl, pH 1.2), simulated gastric fluid, (SGF, pH 1.3) without pepsin and simulated intestinal fluid (SIF, pH 7.2) without pancreatin. There was significant retardation of drug release in all three media as the polymer concentration increased. A burst release was achieved within 60 min (1 h), after which there was a gradual and sustained release of the drug over 7 h. Theophylline release was faster in the alkaline medium (SIF) than in the acidic media (0.1 N HCl and SGF). The mechanism of release of the formulations at all concentrations of the polymer matrix was dominantly diffusion controlled (Fickian or Case I).
Keywords
Theophylline Hydrate, Carbopol 971, Dissolution Studies, Sustained Release, In vitro, Matrix
Reference
[01] | Alderman DA (1984). A Review of Cellulose Ethers in Hydrophyillic Matrices for Oral Controlled Release Dosage Forms, (3), Int. J. Tech. Prod. Manuf. 5 1 – 9 |
[02] | Armstrong NA (1990). ‘Tabletting’ in Aulton M.E.(ed.) Pharmaceutics:‘The Science of Dosage Form Design’ ELBS, Churchill Livingstone, London, p.663. |
[03] | Aulton ME (2002) ‘Pharmaceutics’ The Science of Dosage Form Design, 2nd ed., Churchill Livingstone, Spain, pp. 269 – 308. |
[04] | Banker GS, Anderson NR (1991). Tablets In ‘Theory and Practice of Industrial Industrial Pharmacy’ Lachman and Lieberman (editors) CBS Publishing House,Bombay, pp. 293 – 329. |
[05] | Blake A, Kelly H (2006). ‘Asthma’ in Helms R.A., Quan DJ, Herfinda ET, Ganley DR, Textbook Of Therapeutics : Drug and Disease Management, Lippincott and Williams, Philadelphia, p.898. |
[06] | British Pharmacopoiea, (2009). Appendix XIIB: A 467 – 468. |
[07] | Brown HP (1957). US Patent No 2798053 |
[08] | Chang RK (2004). Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem. US. Pat. Appl. Publ. No.20042693. |
[09] | Chukwu A, Ofoefule SI, Ugoeze K (1997). Studies on the Pharmaceutical Application of a Polysaccharide Derived From Treculia africana fruit, Farm Chim. Boll, 136 (8) : 539 – 544. |
[10] | Cohen JG (1975). In Analytical Profiles of Drug Substances. Florey, K.(ed) Academic Press, New York: 180. |
[11] | Florence AT, Juni PU (1994).‘Novel Drug Formulations – Their potential in Modulating Adverse Effects,’ Drug Saf. 410 (3), 233 – 266. |
[12] | Hongtau LI, Robert JH, Xianchang G (2008) Effect of Drug Solubility on Polymer Hydration and Drug Dissolution From Polyethylene Oxide (PEO) Matrix Tablets, Pharm. Sci. Tech 9 (2): 437 – 443. |
[13] | Khurahashi H, Kanni H, Sunada H (1996). Influence of Physico chemical Properties on Drug Release Rate from Hydroxypropylmethylcellulose matrices. Chem. Pharm. Bull. 44, 829-832. |
[14] | Lubrizol Pharmaceutical Bulletin, (2011). Formulating Controlled Release Tablets and Capsules with Carbopol Polymers.31st edition. |
[15] | Nerurker J, Jun HW, Price JC, Park M (2005). Controlled Release Matrix Tablet of Ibuprofen using Cellulose, Ethers and Carregeenans: Effect of Formulation Factors on Dissolution Rate. Eur. J Pharm. Biopharm.61; 56-68. |
[16] | Ofoefule SI (2002). A textbook of Pharmaceutical Technology and Industrial Pharmacy, Samakin (Nig) Ent. Lagos,: 57 – 66. |
[17] | Okorie O (2004). Some physicochemical and in Vitro Bioadhesive Properties of Deffated Detarium Gum, Quill and Sperr, Ph.D. Thesis (Unpublished) Department of Pharmaceutics and Pharmaceutical Technology, University of Nigeria, Nsukka, |
[18] | Osadebe PO, Akabuogu IC (2004). Assessment of quality control formulations and interchangeability of multi – sourced metformin hydrochloride tablets in Nigeria, Boll Chim Famacia Anna.149 (4), Maggio, 170 – 173. |
[19] | Peppas NA (1985). Analysis of Fickian and non Fickian drug release from polymers, Pharma Acta Helv. 60 : 110 – 111. |
[20] | Parojcic J, Duric Z, Jovanovic M, Ibric S, Jovanovic D (2004). Influence of Dissolution Media Composition on Drug Release and In – vitro In – vivo Correlation for Paracetamol Matrix tablets Prepared with Novel Carbomer Polymers, J. Pharm. Pharmacol. 56 (6), 735 – 741. |
[21] | Saha N, Zhang G, Apelian V, Zang F, Infeld MH, Malick AW (1993).Prediction of Drug Release From Hydroxypropylmethylcellulose (HPMC) matrices: Effect of Polymer Concentration, Pharm. Res. 10., 1673-1695.. |
[22] | Skong JW, Mikelson MV, Vigneron CN, Stemm NL (1993). Qualitative Evaluation of The Mechanism of Release of Matrix Sustained Release Dosage Forms By Measurement of Polymer Release. J. Control Rel. 27: 227-245. |
[23] | Taukder MM, Michael A, Rombaut P, Konget R, (1996). Comparative Study of Xanthan Gum and Hydroxypropylmethylcellulose as Matrices for Controlled Release Behavior, Int. J. Pharm. 129 : 231 – 241. |
[24] | The United States Pharmacopoiea/NF (2009). The United States Pharmacopoieal Convention, 12601, Twinbrook, Parkway, Rockville, M.D. 2085: 382 – 386, 3707. |
[25] | Yang l, Venkatesh G, Fassihi R (1996). Characterization of Compressibility and Compactibility Of Poly(ethylene oxide) polymers for modified release application by compaction simulator, J. Pharm. Sci. 85, 1085-1090. |